To examine the transcriptional reprogramming associated with MYC-driven prostate cancer initiation, we compared a 12-week-old mouse that overexpresses an ARR2Pb driven human c-MYC transgene (MYC) in the prostate epithelium to a wild-type (WT) littermate14. The gene discussed is MYC; the disease is prostate cancer.